Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

STRATA Skin Sciences (SSKN) Debt to Equity (2016 - 2025)

STRATA Skin Sciences' Debt to Equity history spans 13 years, with the latest figure at $11.65 for Q3 2025.

  • For Q3 2025, Debt to Equity rose 622.86% year-over-year to $11.65; the TTM value through Sep 2025 reached $11.65, up 622.86%, while the annual FY2024 figure was $3.06, 157.7% up from the prior year.
  • Debt to Equity for Q3 2025 was $11.65 at STRATA Skin Sciences, down from $28.7 in the prior quarter.
  • Across five years, Debt to Equity topped out at $28.7 in Q2 2025 and bottomed at $0.02 in Q2 2021.
  • The 5-year median for Debt to Equity is $0.89 (2023), against an average of $3.09.
  • The largest annual shift saw Debt to Equity plummeted 79.47% in 2021 before it surged 1705.29% in 2025.
  • A 5-year view of Debt to Equity shows it stood at $0.29 in 2021, then increased by 18.91% to $0.34 in 2022, then soared by 246.24% to $1.19 in 2023, then soared by 157.7% to $3.06 in 2024, then soared by 281.33% to $11.65 in 2025.
  • Per Business Quant, the three most recent readings for SSKN's Debt to Equity are $11.65 (Q3 2025), $28.7 (Q2 2025), and $5.11 (Q1 2025).